(18)F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab

PURPOSE: We evaluated the prognostic value of (18)F-sodium fluoride (NaF) PET/CT in patients with urological malignancies treated with cabozantinib and nivolumab with or without ipilimumab. METHODS: We prospectively recruited patients with advanced urological malignancies into a phase I trial of cab...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Ilhan, Lindenberg, Maria Liza, Mena, Esther, Verdini, Nicholas, Shih, Joanna H., Mayfield, Christian, Thompson, Ryan, Lin, Jeffrey, Vega, Andy, Mallek, Marissa, Cadena, Jacqueline, Diaz, Carlos, Mortazavi, Amir, Knopp, Michael, Wright, Chadwick, Stein, Mark, Pal, Sumanta, Choyke, Peter L., Apolo, Andrea B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885023/
https://www.ncbi.nlm.nih.gov/pubmed/31522271
http://dx.doi.org/10.1007/s00259-019-04483-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885023/
https://www.ncbi.nlm.nih.gov/pubmed/31522271
http://dx.doi.org/10.1007/s00259-019-04483-5

Ejemplares similares